PerkinElmer to buy Euroscreen Products

PerkinElmer announced a deal to buy Belgium's Euroscreen Products for an undisclosed sum. Euroscreen markets products to laboratories engaged in drug discovery work. This is ElmerPerkin's seventh acquisition of the year. "This transaction would represent the next step in our strategy to build the most comprehensive offering in cellular screening and drug discovery reagent technologies," said PerkinElmer chairman and chief executive Gregory L. Summe.

- read the report on the acquisition from The Boston Globe

Suggested Articles

Monte Rosa Therapeutics raised $96 million to ramp up its pipeline of "molecular glue"

Silverback Therapeutics reeled in $85 million to advance its lead antibody-drug conjugate through the clinic and develop its earlier-stage pipeline.

The reported requirements suggest a company is unlikely to have the data needed to support an EUA before the election in six weeks.